U.S. public health agency validated digital PCR technologies – including QIAcuity – as the way to reliably detect multiple disease targets in wastewater samples QIAcuity previously awarded U.S. contract for public health labs utilization in 70% of all U.S. states QIAGEN offers broad portfolio to address demands for testing beyond pandemic HILDEN, Germany & GERMANTOWN, […]

Agilent Technologies Inc. (NYSE: A) today announced that previously CE-IVD marked instruments, kits, and reagents were released as IVDR Class A on May 26, 2022, in compliance with the new EU IVDR regulation. This launch of IVDR-compliant Class A products ensures that labs in the EU who rely on Agilent IVDR instruments, kits, and reagents in […]

To promote integrated solution developments in electron microscope and probe microscope related businesses by strengthened collaborations with customers Tokyo – Hitachi High-Tech Corporation (Hitachi High-Tech) today announced the opening of its new demonstration and collaboration base “Advanced-Technology Innovation Center Naka (ACN)” in the city of Hitachinaka, Ibaraki Prefecture. This facility will function as a site to […]

To promote integrated solution developments in electron microscope and probe microscope related businesses by strengthened collaborations with customers TOKYO – Hitachi High-Tech Corporation today announced the opening of its new demonstration and collaboration base “Advanced-Technology Innovation Center Naka (ACN)” in the city of Hitachinaka, Ibaraki Prefecture. This facility will function as a site to demonstrate […]

Bio-Techne is extending ACD’s leadership in the spatial biology market by passing a milestone of offering 40,000 custom probes in over four hundred species MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced Advanced Cell Diagnostics (ACD), a brand of Bio-Techne, reached an extraordinary milestone of developing over 40,000 unique RNAscope in situ Hybridization (ISH) probes in over 400 […]

Highlights include the launch of Spectronaut® 16, which has undergone one of its most transformative upgrades to date, and innovations to Biognosys’ proprietary TrueTarget™ and TrueDiscovery™ platforms for drug and biomarker discovery. ZURICH — Biognosys AG, a leading inventor and developer of mass spectrometry-based proteomics solutions, today announced the company is attending the American Society for […]

Company Moves to Make Total Cell Analysis Solutions Available for Clinical Applications in the European Market FREMONT, Calif. — Clinical flow cytometry laboratories based in Europe can now purchase Cytek cFluor® CE-IVD-certified reagents for their use. Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that a series of single-color cFluor reagents and a […]

First companion diagnostic claim for Illumina’s TruSight™ Oncology Comprehensive (EU) test enables targeted therapy with Bayer’s VITRAKVI® (larotrectinib) for patients with NTRK fusion cancer SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the addition of a companion diagnostic (CDx) indication to its CE-marked in vitro diagnostic TruSight™ Oncology (TSO) Comprehensive (EU) […]

The Emanuel Merck Lectureship was jointly established by Merck and TU Darmstadt in 1992. It recognizes globally renowned scientists who have made superb contributions to chemical and pharmaceutical research. DARMSTADT, GERMANY Outstanding scientific work in the field of metallo-organic chemistry honored Co-discoverer of the Buchwald-Hartwig amination 17th joint award presented by TU Darmstadt and Merck Merck, […]